Grufity logoGrufity logo

ELAN

12.74USD-0.11(-0.86%)Delayedas of 06 Dec 2022, 01:00 pm

Elanco Animal Health Inc

Market Summary

USD12.74-0.11Delayedas of 06 Dec 2022, 01:00 pm
-0.86%

ELAN Alerts

ELAN Stock Price

RSI Chart

Valuation

Market Cap

6.4B

Price/Earnings

-36.63

Price/Sales

1.38

Price/Cashflow

11.41

MarketCap/EBT

-32.37

Price/Sales

Profitability

EBT Margin

-4.26%

Return on Equity

-2.45%

Return on Assets

-1.12%

Fundamentals

Revenue

Revenue (TTM)

4.5B

Revenue Y/Y

-9.11%

Revenue Q/Q

-12.66%

Earnings

Earnings (TTM)

-120.0M

Earnings Y/Y

52.88%

Earnings Q/Q

-122.73%

Price Action

52 Week Range

11.3429.76
(Low)(High)

Last 7 days

5.8%

Last 30 days

-1.4%

Last 90 days

-12.1%

Trailing 12 Months

-54.4%

Financial Health

Current Ratio

2.47

Debt/Equity

0.85

Debt/Cashflow

0.09

Investor Care

Shares Dilution (1Y)

0.23%

Diluted EPS (TTM)

-0.24

Peers (Alternatives to Elanco Animal Health)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
459.8B
96.0B
4.93% 15.12%
24
4.79
5.02% 7.14%
342.0B
29.2B
3.61% 52.43%
60.08
11.76
5.34% 1.02%
266.2B
99.7B
7.43% -3.49%
9.08
2.63
43.92% 53.21%
255.3B
57.2B
10.90% 55.26%
15.4
4.47
35.88% 197.59%
163.4B
46.7B
2.44% 47.74%
24.47
3.5
2.79% 223.53%
MID-CAP
5.5B
4.4B
-18.98% -9.87%
-46.93
1.26
1.80% 57.67%
SMALL-CAP
1.9B
628.4M
22.83% -47.71%
-4.08
3.1
64.35% -18.14%
1.9B
659.0M
4.74% 17.18%
32.36
2.95
16.78% -53.92%
1.5B
-
31.31% -56.76%
-0.54
1.95
-4.11% -144.36%
1.2B
112.7M
13.64% -15.87%
-10.75
7.76
-54.94% 40.20%
1.1B
3.1M
20.39% -49.65%
-3.57
108.75
-77.09% -12.24%
1.0B
23.5M
3.23% 25.20%
-12.31
166.87
243.57% -1.04%
945.9M
373.2M
-0.39% -20.97%
4.56
2.34
-0.39% -38.45%
283.2M
49.7M
-14.57% -51.46%
-8.71
5.67
28.95% 32.80%
68.8M
2.6B
-43.99% -88.43%
-0.03
0.02
-13.88% -4855.92%

Financials for Elanco Animal Health

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue-2.2%4,5434,6464,7484,7654,792
  S&GA Expenses-3.3%1,2901,3341,3761,4041,449
  R&D Expenses-4.6%333349361369390
Earnings Before Taxes44.4%-110.00-198.00-416.00-567.00-764.10
Net Income31.4%-120.00-175.00-363.00-472.00-697.80
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets-4.2%14,94815,60116,25116,48316,565
  Current Assets-4.6%3,1543,3073,1943,2763,160
    Cash Equivalents-9.3%460507342638453
  Inventory0.4%1,3401,3341,3451,3731,383
  Net PPE-2.6%9369619871,0611,041
  Goodwill-3.1%5,7165,8986,1166,1726,191
Liabilities-3.0%8,2038,4618,6398,9458,883
  Current Liabilities20.6%1,6131,3381,3071,6431,362
  Long Term Debt-2.7%5,9016,0636,1346,3196,334
    LT Debt, Current603.6%394566129461
    LT Debt, Non Current-8.3%5,5076,0076,0736,0256,273
Shareholder's Equity-5.5%6,7457,1407,6127,5387,682
  Retained Earnings-5.3%-972.00-923.00-901.00-949.00-852.00
  Additional Paid-In Capital0.1%8,7248,7128,6998,6968,680
Accumulated Depreciation1.2%6966886701,0411,050
Shares Outstanding0.0%474474474473473
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations17.8%662562399483167
  Share Based Compensation-6.1%6266656665
Cashflow From Investing69.5%-177.00-581.00-569.00-530.00-530.00
Cashflow From Financing-1904.8%-421.00-21.008210148

Risks

What is the probability of a big loss on ELAN?

64.0%


Probability that Elanco Animal Health stock will be more than 20% underwater in next one year

43.2%


Probability that Elanco Animal Health stock will be more than 30% underwater in next one year.

32.9%


Probability that Elanco Animal Health stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does ELAN drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Elanco Animal Health was unfortunately bought at previous high price.

Returns

Cumulative Returns on ELAN

-22.0%


3-Year Cumulative Returns

Which funds bought or sold ELAN recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-29
Bridgefront Capital, LLC
-
-
-188,000
306,000
0.31%
2022-11-23
Eagle Bay Advisors LLC
REDUCED
-29.51
-29,824
23,000
0.01%
2022-11-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
NEW
-
2,614,000
2,614,000
0.03%
2022-11-22
CVA Family Office, LLC
NEW
-
2,000
2,000
-%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
-
-
-5,304,000
8,902,000
0.01%
2022-11-21
17 CAPITAL PARTNERS, LLC
-
-
-203,000
432,000
0.59%
2022-11-21
Parallax Volatility Advisers, L.P.
NEW
-
1,282,000
1,282,000
-%
2022-11-18
Legend Financial Advisors, Inc.
NEW
-
6,205
6,205
0.01%
2022-11-17
M&T Bank Corp
-
-
-1,656,000
2,911,000
0.01%
2022-11-16
CAPTRUST FINANCIAL ADVISORS
SOLD OFF
-100
-252,000
-
-%

1–10 of 43

Latest Funds Activity

Are funds buying ELAN calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own ELAN

Elanco Animal Health News

Stocks Register

Elanco Animal Health Incorporated (NYSE: ELAN)'s Stock Hinders -1.97%, But It May Be A Worthy Investment.25 hours ago

ELAN Fair Value

Recent SEC filings of Elanco Animal Health

View All Filings
Date Filed Form Type Document
Nov 15, 2022
4
Insider Trading
Nov 10, 2022
SC 13G/A
Major Ownership Report
Nov 08, 2022
8-K
Current Report
Nov 08, 2022
10-Q
Quarterly Report
Nov 03, 2022
4
Insider Trading
Nov 02, 2022
4
Insider Trading
Nov 02, 2022
4
Insider Trading
Nov 02, 2022
4
Insider Trading
Oct 04, 2022
4
Insider Trading
Oct 04, 2022
4
Insider Trading

Latest Insider Trading transactions for ELAN

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-30
Harrington Michael J
ACQUIRED
-
-
18,649
-
2022-11-30
Kochevar Deborah Turner
ACQUIRED
-
-
18,649
-
2022-11-30
DOYLE WILLIAM F
ACQUIRED
-
-
18,649
-
2022-11-30
McDonald Kirk P
ACQUIRED
-
-
18,649
-
2022-11-30
Herendeen Paul
ACQUIRED
-
-
18,649
-
2022-11-30
HOOVER R DAVID
ACQUIRED
-
-
18,649
-
2022-11-30
BILBREY JOHN P
ACQUIRED
-
-
18,649
-
2022-11-30
GARCIA ART A
ACQUIRED
-
-
18,649
-
2022-11-30
Scots-Knight Denise
ACQUIRED
-
-
18,649
-
2022-11-30
Anand Kapila K
ACQUIRED
-
-
18,649
-

1–10 of 50

Jeffrey N. Simmons
9800
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

ELAN Income Statement

2022-09-30
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]    
Revenue$ 1,028$ 1,131$ 3,430$ 3,652
Costs, expenses and other:    
Cost of sales4725021,4651,622
Research and development7894241277
Marketing, selling and administrative2983429611,075
Amortization of intangible assets128141398417
Asset impairment, restructuring and other special charges26111158518
Interest expense, net of capitalized interest6060179181
Other expense, net811178
Costs, expenses and other1,0701,2613,4194,098
Income (loss) before income taxes(42)(130)11(446)
Income tax expense (benefit)7(26)34(71)
Net loss$ (49)$ (104)$ (23)$ (375)
Loss per share:    
Basic (usd per share)$ (0.10)$ (0.21)$ (0.05)$ (0.77)
Diluted (usd per share)$ (0.10)$ (0.21)$ (0.05)$ (0.77)
Weighted average shares outstanding:    
Basic (in shares)488.4487.3488.3487.1
Diluted (in shares)488.4487.3488.3487.1

ELAN Balance Sheet

2022-09-30
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Current Assets  
Cash and cash equivalents$ 460$ 638
Accounts receivable, net of allowances of $10 (2022) and $12 (2021)804833
Other receivables224195
Inventories1,3401,373
Prepaid expenses and other326237
Total current assets3,1543,276
Noncurrent Assets  
Goodwill5,7166,172
Other intangibles, net4,7665,587
Other noncurrent assets376387
Property and equipment, net of accumulated depreciation of $696 (2022) and $1,041 (2021)9361,061
Total assets14,94816,483
Current Liabilities  
Accounts payable350418
Employee compensation136185
Sales rebates and discounts298316
Current portion of long-term debt394294
Other current liabilities435430
Total current liabilities1,6131,643
Noncurrent Liabilities  
Long-term debt5,5076,025
Accrued retirement benefits240271
Deferred taxes618745
Other noncurrent liabilities225261
Total liabilities8,2038,945
Commitments and Contingencies
Equity  
Preferred stock, no par value, 1,000,000,000 shares authorized; none issued00
Common stock, no par value, 5,000,000,000 shares authorized, 474,124,115 and 473,119,786 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively00
Additional paid-in capital8,7248,696
Accumulated deficit(972)(949)
Accumulated other comprehensive loss(1,007)(209)
Total equity6,7457,538
Total liabilities and equity$ 14,948$ 16,483